TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
Key Highlights
- ➤TelyRx will report Q3 2026 results after market close November 5
- ➤TelyRx schedules Q3 2026 results conference call for November 6 at 8:30 a.m. ET
- ➤TelyRx serves patients across 48 U.S. states and all territories
- ➤TelyRx offers more than 500 FDA-approved medications across over 60 conditions
Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, via news release after market close on Thursday, November 5, 2026.
The Company will host a conference call to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). To dial direct and enter the call through an operator, dial 1-833-752-3490 or 1-647-260-0811. The live webcast can be accessed by copying and pasting this link into a browser: https://www.gowebcasting.com/15175. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.
Get started
Create a free account to read the full story.